135 related articles for article (PubMed ID: 2906393)
1. Pharmacodynamic effects of a 2-piperazinotetralin (P-11)--combined alpha- and beta-adrenoceptor blocking drug with hypotensive action.
Mutafova-Yambolieva V; Staneva-Stoytcheva D
Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):551-7. PubMed ID: 2906393
[TBL] [Abstract][Full Text] [Related]
2. Involvement of peripheral dopaminergic mechanisms in the action of a 2-piperazinotetralin (P-11) with hypotensive activity.
Mutafova-Yambolieva V; Staneva-Stoytcheva D
Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):559-62. PubMed ID: 2906394
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the blood pressure of beta-adrenoceptor blocking drugs, particularly in relation to the mechanism of the pressor action induced by beta-adrenoceptor blocking drugs in rats (author's transl)].
Maekawa H
Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):251-61. PubMed ID: 6124489
[TBL] [Abstract][Full Text] [Related]
4. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
Hopkins BJ; Hodgson WC; Sutherland SK
Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
[TBL] [Abstract][Full Text] [Related]
6. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
7. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
[TBL] [Abstract][Full Text] [Related]
8. [Adrenergic mechanisms in the hypotensive action of a piperazine derivative of 2-aminotetralin].
Mutafova-Iambolieva V; Staneva-Stoĭcheva D
Eksp Med Morfol; 1985; 24(1):8-12. PubMed ID: 2992908
[No Abstract] [Full Text] [Related]
9. [Difference of tolerances to isoprenaline between tracheal and vascular smooth muscles and cardiac conduction system in guinea pigs].
Zhao SJ; Sun GL; Cao YS
Zhongguo Yao Li Xue Bao; 1990 May; 11(3):210-3. PubMed ID: 1965090
[TBL] [Abstract][Full Text] [Related]
10. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
Lindner E
Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430
[TBL] [Abstract][Full Text] [Related]
11. [Hypotensive and antihypertensive activity of a newly synthesized derivative of 2-aminotetralin].
Raĭnova L; Georgieva A; Staneva-Stoĭcheva D
Eksp Med Morfol; 1978; 17(1):37-43. PubMed ID: 25170
[TBL] [Abstract][Full Text] [Related]
12. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
14. Capsinolol: the first beta-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart.
Chen IJ; Yeh JL; Lo YC; Sheu SH; Lin YT
Br J Pharmacol; 1996 Sep; 119(1):7-14. PubMed ID: 8872350
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the beta-adrenoceptors of guinea-pig, rabbit and rat trachea.
Rajani AP; Shah DS; Gulati OD
Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):190-8. PubMed ID: 203236
[TBL] [Abstract][Full Text] [Related]
16. Extremely long-acting antihypertensive effects of KF-4317, a alpha- and beta 1-adrenoceptor blocker.
Kubo K; Ikeda J; Nakamura J; Nakamizo N
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):140-60. PubMed ID: 2865934
[TBL] [Abstract][Full Text] [Related]
17. Isoeugenolol: a selective beta1-adrenergic antagonist with tracheal and vascular smooth muscle relaxant properties.
Lin YT; Wu BN; Horng CF; Huang YC; Hong SJ; Lo YC; Cheng CJ; Chen IJ
Jpn J Pharmacol; 1999 Jun; 80(2):127-36. PubMed ID: 10440531
[TBL] [Abstract][Full Text] [Related]
18. [The hypotensive effects and mechanism of SGB-483, a newly-synthesized hypotensive agent].
Chin W; Nakagawa Y; Mitomi A; Imai S
Nihon Yakurigaku Zasshi; 1982 May; 79(5):441-9. PubMed ID: 6127291
[TBL] [Abstract][Full Text] [Related]
19. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
[TBL] [Abstract][Full Text] [Related]
20. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
Constantine JW; Lebel W; Weeks R
J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
